v0.48.01

Try our Chrome extension

Chrome Webstore

Easily add the current web-page from your browser directly into your changedetection.io tool, more great features coming soon!

Changedetection.io needs your support!

You can help us by supporting changedetection.io on these platforms;

The more popular changedetection.io is, the more time we can dedicate to adding amazing features!

Many thanks :)

changedetection.io team

Not yet seconds ago
            False
        
Not yet seconds ago
Current erroring screenshot from most recent request
2 hours ago
Pro-tip: Highlight text to add to ignore filters
          * Home
          * About Us
          * Team
          * Portfolio
          * News
          * Investors
          * Fellowship
          * Contact
      Created with Sketch.

            Bold investment in
            the future of medicine

            Representative Portfolio Companies”

                      A2 Biotherapeutics

                      Advanced biologics technology platform for next-gen immunotherapies

                      Affini-T Therapeutics

                      Unlocking the power of T cells against oncogenic driver mutations

                      Aktis Oncology

                      Discovering and developing a novel class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers

                      Allogene Therapeutics

                      Allogeneic CAR T (AlloCAR T ™) therapies for cancer
                      (NASDAQ: ALLO)

                      Alterome Therapeutics

                      Developing alteration-specific targeted therapies for the treatment of cancer

                      Asklepios BioPharmaceutical

                      Focused on discovering, developing and manufacturing next-generation, transformative TCR therapies targeting neoantigens in solid cancers

                      Acquired by Bayer in 2020

                      Avalyn Pharma

                      Developing targeted inhalation therapies for life-threatening pulmonary diseases

                      Candid Therapeutics

                      Developing potentially transformative drugs to address autoimmune diseases

                      Capstan Therapeutics

                      Developing therapeutics to reprogram immune cells for a broad range of diseases

                      Centessa Pharmaceuticals

                      A novel asset-centric pharmaceutical company designed and built to advance a portfolio of highly validated programs
                      (NASDAQ: CNTA)

                      Dyne Therapeutics

                      Developing life-transforming therapies for patients with serious muscle diseases
                      (NASDAQ: DYN)

                      Halda Therapeutics

                      Developing a novel class of cancer therapies called RIPTACTM (Regulated Induced Proximity Targeting Chimeras) therapeutics

                      IconOVir Bio

                      Pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer

                      InduPro

                      Developing novel therapeutics based on identification and manipulation of protein pairings

                      Kronos Bio

                      Pursuing therapies against some of the most intractable cancer targets
                      (NASDAQ: KRON)

                      Kyverna Therapeutics

                      Developing cell therapies to treat autoimmune diseases
                      (NASDAQ: KYTX)

                      LB Pharmaceuticals

                      Developing innovative therapies for neuropsychiatric diseases, including schizophrenia

                      Neogene Therapeutics

                      Personalized T cell therapies to treat cancer

                      Acquired by AstraZeneca in 2023

                      Peloton Therapeutics

                      Advancing first-in-class small molecule therapies

                      Acquired by Merck in 2019

                      Precision Medicine Group

                      Supporting biopharmaceutical clients through clinical development and commercialization

                      Protego Biopharma

                      Dedicated to finding novel solutions for protein misfolding diseases

                      Quanta Therapeutics

                      Pioneering complex-directed therapies to treat RAS-driven cancer types

                      ReCode Therapeutics

                      Targeting the underlying genetic cause of disease for underserved patients

                      Scorpion Therapeutics

                      Target Engaged: Broadening the reach and impact of precision medicine for oncology

                      Tectonic Therapeutic

                      Transforming the discovery of novel G-protein-coupled receptors (GPCR)-targeted therapies

                      Third Arc Bio

                      Developing multifunctional antibodies that are optimized for best-in-class T cell engagement across solid tumors and inflammatory & immunology (I&I) disease

                      Vigil Neuroscience

                      Harnessing the power of microglia for the treatment of neurodegenerative diseases
                      (NASDAQ: VIGL)

                      Volastra Therapeutics

                      Developing novel therapies for the prevention and treatment of metastatic cancer

            * 
            * 

          Transforming biomedical innovations into therapies

          Make a meaningful difference in patients’ lives

          © 2025 Vida Ventures, LLC

            * Home
            * About Us
            * Team
            * Portfolio
            * News
            * Investors
            * Fellowship
            * Contact
  Top
                        
For now, Differences are performed on text, not graphically, only the latest screenshot is available.

Screenshot requires Playwright/WebDriver enabled